STAGE I BLADDER CANCER AJCC V8
Clinical trials for STAGE I BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy may replace chemo in Bladder-Sparing cancer treatment
Disease control Recruiting nowThis study tests whether combining an immunotherapy drug (pembrolizumab) with radiation works better than standard chemotherapy plus radiation for people with a high-risk, early-stage bladder cancer that hasn't spread into the muscle. About 160 participants will receive either tr…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 10:42 UTC
-
Bladder cancer gets a targeted attack: new micelle therapy enters human trials
Disease control Recruiting nowThis early-stage trial tests a new treatment called PPM for people with a type of bladder cancer that has returned or not responded to standard therapy. PPM uses tiny particles (micelles) coated with a targeting molecule to deliver a chemotherapy drug directly to cancer cells in …
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New vaccine combo aims to outsmart bladder cancer when standard therapy fails
Disease control Recruiting nowThis early-stage trial tests a new vaccine (IO102-IO103) plus the immunotherapy drug pembrolizumab in 30 adults with a type of bladder cancer that didn't get better with standard BCG therapy. The vaccine is designed to train the body's immune cells to recognize and attack the can…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New combo therapy aims to beat back bladder cancer recurrence
Disease control Recruiting nowThis phase 3 trial tests whether adding the chemotherapy drug gemcitabine to standard BCG immunotherapy can better prevent bladder cancer from coming back. About 330 people with recurrent high-grade non-muscle invasive bladder cancer will receive either BCG alone or BCG plus gemc…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Bladder cancer care comes home: new trial tests In-House chemo
Symptom relief Recruiting nowThis study tests whether giving chemotherapy directly into the bladder at home is safe and works as well as doing it in a clinic. About 40 people with early-stage bladder cancer will receive their usual treatment at home. The goal is to see if home treatment reduces disruption to…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC